Cargando…
Molecular Bases of Drug Resistance in Hepatocellular Carcinoma
The poor outcome of patients with non-surgically removable advanced hepatocellular carcinoma (HCC), the most frequent type of primary liver cancer, is mainly due to the high refractoriness of this aggressive tumor to classical chemotherapy. Novel pharmacological approaches based on the use of inhibi...
Autores principales: | Marin, Jose J.G., Macias, Rocio I.R., Monte, Maria J., Romero, Marta R., Asensio, Maitane, Sanchez-Martin, Anabel, Cives-Losada, Candela, Temprano, Alvaro G., Espinosa-Escudero, Ricardo, Reviejo, Maria, Bohorquez, Laura H., Briz, Oscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352164/ https://www.ncbi.nlm.nih.gov/pubmed/32585893 http://dx.doi.org/10.3390/cancers12061663 |
Ejemplares similares
-
Mechanisms of Anticancer Drug Resistance in Hepatoblastoma
por: Marin, Jose J. G., et al.
Publicado: (2019) -
Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
por: Marin, Jose J. G., et al.
Publicado: (2022) -
Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment
por: Marin, Jose J.G., et al.
Publicado: (2020) -
Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma
por: Marin, Jose J. G., et al.
Publicado: (2020) -
Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma
por: Marin, Jose J.G., et al.
Publicado: (2020)